Monthly Archives: September 2010

Hearing Update: Novartis argues that section 3(d) not applicable to its patent application

12 September 2012, New Delhi. Continuing arguments on behalf of Novartis, Mr Gopal Subramaniam, senior counsel, took the Bench through the Complete Specification of Novartis’ patent application for the beta-crystalline form of imatinib mesylate that was filed before the Patent